منو
  جست و جو
  ورود اعضا
  عضویت
English
ورود اعضا
عضویت
عضویت در سایت

Maryam Tohidi

In the Name of God

Personal Details

Full Name: Maryam Tohidi, MD, Associate professor of anatomical & clinical pathology

Telephone: +98 21 2243 2500 (ext. 320)

Fax: +98 21 2241 6264 / +98 21 2240 2463

E،mail: tohidi@endocrine.ac.ir

https://isid.research.ac.ir/Maryam_Tohidi

Education

  • Board of Anatomical & Clinical Pathology

Shahid Beheshti University of Medical Sciences, Tehran, Iran, 2000                                                                                                                                                                            

  • M.D              

Shahid Beheshti University of Medical Sciences, Tehran, Iran. 1993                                                                                                                                                                            

 

 

 

Career Summary

  • Academic member, Prevention of Metabolic Disorders Research Centre, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran         

                                                                                                                                            October 2004– Present

 

  • Director of hormone laboratory of Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran                                                                     2005- present

 

  • Academic member, Hormozgan University of Medical Sciences, Tehran, Iran            

                                                                                                                   November 2000، September 2008

 

Membership of Professional Bodies

  • Iranian Medical Council, 1993
  • Iranian society of pathology, 2000
  • Iran Endocrine Society, 2005

 

 

Peer Reviewed Publications

English

  1. Increased remission rates after long-term methimazole therapy in patients with Graves' disease: Results of a randomized clinical trial. Azizi F, Amouzegar A, Tohidi M, Hedayati M, Khalili D, Cheraghi L, Mehrabi Y, Takyar M. Thyroid. 2019 Jul 16. doi: 10.1089/thy.2019.0180.
  2. Long-Term Variations of Antithyroperoxidase Antibodies and its Clinical Significance. Keyhanian M, Sarvghadi F, Mehran L, Amouzegar A, Beigy M, Tohidi M, Azizi F. Horm Metab Res. 2019 Jun;51(6):347-352. doi: 10.1055/a-0887-6213. Epub 2019 Jun 17.
  3. Trend of lipid and thyroid function tests in adults without overt thyroid diseases: A cohort from Tehran thyroid study. Ahi S, Amouzegar A, Gharibzadeh S, Delshad H, Tohidi M, Azizi F. PLoS One. 2019 May 16; 14(5):e0216389. doi: 10.1371/journal.pone.0216389. eCollection 2019.
  4. Overtime trend of thyroid hormones and thyroid autoimmunity and ovarian reserve: a longitudinal population study with a 12-year follow up. Bahri S, Tehrani FR, Amouzgar A, Rahmati M, Tohidi M, Vasheghani M, Azizi F. BMC Endocr Disord. 2019 May 7; 19(1):47. doi: 10.1186/s12902-019-0370-7.
  5. High prevalence of benign mammary tumors in a rat model of polycystic ovary syndrome during postmenopausal period. Noroozzadeh M, Behboudi-Gandevani S, Mosaffa N, Tohidi M, Ramezani Tehrani F. Gynecol Endocrinol. 2019 Aug; 35(8):679-684. doi: 10.1080/09513590.2019.1576613. Epub 2019 Apr 16.
  6. Effect of long-term sodium nitrate administration on diabetes-induced anemia and glucose homeostasis in obese type 2 diabetic male rats. Khorasani V, Jeddi S, Yaghmaei P, Tohidi M, Ghasemi A. Nitric Oxide. 2019 May 1; 86:21-30. doi: 10.1016/j.niox.2019.02.003. Epub 2019 Feb 14.
  7. The association between serum total testosterone and progression of hyperglycemia: a 15-year prospective cohort study. Minooee S, Ramezani Tehrani F, Rahmati M, Amanollahi Soudmand S, Tohidi M, Sabet Z, Azizi F. Andrology. 2019 Mar; 7(2):148-155. doi: 10.1111/andr.12568. Epub 2019 Jan 21.
  8. Association of circulating 25-hydroxyvitamin D and parathyroid hormone with carotid intima media thickness in children and adolescents with excess weight. Asghari G, Mirmiran P, Yuzbashian E, Dehghan P, Mahdavi M, Tohidi M, Wagner CL, Neyestani T, Hosseinpanah F, Azizi F. J Steroid Biochem Mol Biol. 2018 Dec 31. pii: S0960-0760(18)30463-1. doi: 10.1016/j.jsbmb.2018.12.015.
  9. Diabetes Mellitus: Findings from 20 Years of the Tehran Lipid and Glucose Study. Ramezankhani A, Harati H, Bozorgmanesh M, Tohidi M, Khalili D, Azizi F, Hadaegh F. Int J Endocrinol Metab. 2018 Oct 16; 16(4 Suppl):e84784. doi: 10.5812/ijem.84784. eCollection 2018 Oct. Review.
  10. Blood Pressure and Hypertension: Findings from 20 Years of the Tehran Lipid and Glucose Study (TLGS). Abdi H, Amouzegar A, Tohidi M, Azizi F, Hadaegh F. Int J Endocrinol Metab. 2018 Oct 20; 16 (4 Suppl):e84769. doi: 10.5812/ijem.84769. eCollection 2018 Oct. Review.
  11. Serum Lipids During 20 Years in the Tehran Lipid and Glucose Study: Prevalence, Trends and Impact on Non-Communicable Diseases. Baghbani-Oskouei A, Tohidi M, Asgari S, Ramezankhani A, Azizi F, Hadaegh F. Int J Endocrinol Metab. 2018 Oct 16; 16(4 Suppl):e84750. doi: 10.5812/ijem.84750. eCollection 2018 Oct. Review.
  12. Insulin metabolism markers are predictors of subclinical atherosclerosis among overweight and obese children and adolescents. Asghari G, Dehghan P, Mirmiran P, Yuzbashian E, Mahdavi M, Tohidi M, Neyestani TR, Hosseinpanah F, Azizi F. BMC Pediatr. 2018 Nov 23; 18(1):368. doi: 10.1186/s12887-018-1347-9.
  13. The relationship between clinical and biochemical characteristics and quality of life in patients with polycystic ovary syndrome. Amiri M, Bidhendi Yarandi R, Nahidi F, Tohidi M, Ramezani Tehrani F. Clin Endocrinol (Oxf). 2019 Jan; 90(1):129-137. doi: 10.1111/cen.13858.
  14. Fasting plasma glucose is a stronger predictor of diabetes than triglyceride-glucose index, triglycerides/high-density lipoprotein cholesterol, and homeostasis model assessment of insulin resistance: Tehran Lipid and Glucose Study. Tohidi M, Baghbani-Oskouei A, Ahanchi NS, Azizi F, Hadaegh F. Acta Diabetol. 2018 Oct; 55(10):1067-1074. doi: 10.1007/s00592-018-1195-y.
  15. New modified Friedewald formulae for estimating low-density lipoprotein cholesterol according to triglyceride levels: extraction and validation. Ghasemi A, Asgari S, Hadaegh F, Kheirandish M, Azimzadeh I, Azizi F, Tohidi M. Endocrine. 2018 Nov; 62(2):404-411. doi: 10.1007/s12020-018-1685-2.
  16. Impact of 3-year changes in lipid parameters and their ratios on incident type 2 diabetes: Tehran lipid and glucose study. Khaloo P, Hasheminia M, Tohidi M, Abdi H, Mansournia MA, Azizi F, Hadaegh F. Nutr Metab (Lond). 2018 Jul 11; 15:50. doi: 10.1186/s12986-018-0287-6. eCollection 2018.
  17. Pomegranate Juice Increases Sirtuin1 Protein in Peripheral Blood Mononuclear Cell from Patients with Type 2 Diabetes: A Randomized Placebo Controlled Clinical Trial. Sohrab G, Nasrollahzadeh J, Tohidi M, Zand H, Nikpayam O. Metab Syndr Relat Disord. 2018 Oct; 16(8):446-451. doi: 10.1089/met.2017.0146.
  18.  Endogenous testosterone does not improve prediction of incident cardiovascular disease in a community-based cohort of adult men: results from the Tehran Lipid and Glucose Study. Hatami H, Parizadeh D, Bidhendi Yarandi R, Tohidi M, Ramezani Tehrani F. Aging Male. 2018 Apr 27:1-8. doi: 10.1080/13685538.2018.1466876.
  19. Associations between Thyroid and Blood Pressure in Euthyroid Adults: A 9-Year Longitudinal Study. Abdi H, Gharibzadeh S, Tasdighi E, Amouzegar A, Mehran L, Tohidi M, Azizi F. Horm Metab Res. 2018 Mar;50(3):236-241. doi: 10.1055/s-0044-101756.
  20. High dietary intake of branched-chain amino acids is associated with an increased risk of insulin resistance in adults. Asghari G, Farhadnejad H, Teymoori F, Mirmiran P, Tohidi M, Azizi F. J Diabetes. 2018 May; 10 (5):357-364. doi: 10.1111/1753-0407.12639.
  21. Sexual function in women with polycystic ovary syndrome and their hormonal and clinical correlations. Nasiri Amiri F, Ramezani Tehrani F, Esmailzadeh S, Tohidi M, Azizi F, Basirat Z. Int J Impot Res. 2018 Apr;30(2):54-61. doi: 10.1038/s41443-017-0006-2.
  22. Application of survival tree analysis for exploration of potential interactions between predictors of incident chronic kidney disease: a 15-year follow-up study. Ramezankhani A, Tohidi M, Azizi F, Hadaegh F. J Transl Med. 2017 Nov 28; 15(1):240. doi: 10.1186/s12967-017-1346-x.
  23. Predictors of early adulthood hypertension during adolescence: a population-based cohort study. Kalantari S, Khalili D, Asgari S, Fahimfar N, Hadaegh F, Tohidi M, Azizi F. BMC Public Health. 2017 Nov 28; 17(1):915. doi: 10.1186/s12889-017-4922-3.
  24. Thyroid Dysfunction States and Incident Cardiovascular Events: The Tehran Thyroid Study. Tohidi M, Derakhshan A, Akbarpour S, Amouzegar A, Mehran L, Baghbani-Oskouei A, Azizi F, Hadaegh F. Horm Metab Res. 2018 Jan;50(1):e1. doi: 10.1055/s-0043-123039.
  25. Effects of Levothyroxine on Pregnant Women With Subclinical Hypothyroidism, Negative for Thyroid Peroxidase Antibodies. Nazarpour S, Ramezani Tehrani F, Simbar M, Tohidi M, Minooee S, Rahmati M, Azizi F. J Clin Endocrinol Metab. 2018 Mar 1; 103(3):926-935. doi: 10.1210/jc.2017-01850.
  26. Thyroid dysfunction in patients with impaired glucose metabolism: 11 year follow up from the Tehran Thyroid Study. Gholampour Dehaki M, Amouzegar A, Delshad H, Mehrabi Y, Tohidi M, Azizi F. PLoS One. 2017 Oct 3; 12(10):e0184808. doi: 10.1371/journal.pone.0184808. eCollection 2017.
  27. Adherence to the dietary approaches to stop hypertension trial (DASH) diet is inversely associated with incidence of insulin resistance in adults: the Tehran lipid and glucose study. Esfandiari S, Bahadoran Z, Mirmiran P, Tohidi M, Azizi F. J Clin Biochem Nutr. 2017 Sep; 61(2):123-129. doi: 10.3164/jcbn.16-95.
  28. Longitudinal Associations of High-Fructose Diet with Cardiovascular Events and Potential Risk Factors: Tehran Lipid and Glucose Study. Bahadoran Z, Mirmiran P, Tohidi M, Azizi F. Nutrients. 2017 Aug 21; 9(8). pii: E872. doi: 10.3390/nu9080872.
  29. Association between Thyroid Function and Body Mass Index: A 10-Year Follow-Up. Abdi H, Kazemian E, Gharibzadeh S, Amouzegar A, Mehran L, Tohidi M, Rashvandi Z, Azizi F. Ann Nutr Metab. 2017; 70(4):338-345. doi: 10.1159/000477497.
  30. The Association between Normal Range TSH and Lipid Profile. Ahi S, Amouzegar A, Gharibzadeh S, Kazempour-Ardebili S, Delshad H, Tohidi M, Azizi F. Horm Metab Res. 2017 Jun;49(6):424-429. doi: 10.1055/s-0043-110142.
  31. Variations in serum free thyroxin concentration within normal ranges predict the incidence of metabolic syndrome in non-obese adults: a Cohort Study. Mehran L, Amouzegar A, Bakhtiyari M, Mansournia MA, Kheirkhah Rahimabad P, Tohidi M, Azizi F. Thyroid. 2017 May 9. doi: 10.1089/thy.2016.0557.
  32. Thyroid Function and Metabolic Syndrome: A Population-Based Thyroid Study. Mehran L, Amouzegar A, Rahimabad PK, Tohidi M, Tahmasebinejad Z, Azizi F. Horm Metab Res. 2017 Mar;49(3):192-200. doi: 10.1055/s-0042-117279.
  33.  Role of androgen ratios in the prediction of the metabolic phenotype in polycystic ovary syndrome. Minooee S, Ramezani Tehrani F, Tohidi M, Azizi F. Int J Gynaecol Obstet. 2017 May; 137(2):110-115. doi: 10.1002/ijgo.12107.
  34. Assay-dependent variability of serum insulin concentrations: a comparison of eight assays. Tohidi M, Arbab P, Ghasemi A. Scand J Clin Lab Invest. 2017 Apr; 77(2):122-129. doi: 10.1080/00365513.2016.1278260.
  35. Natural Course of Euthyroidism and Clues for Early Diagnosis of Thyroid Dysfunction: Tehran Thyroid Study. Thyroid.  Amouzegar A, Ghaemmaghami Z, Beigy M, Gharibzadeh S, Mehran L, Tohidi M, Azizi F. 2017 May;27(5):616-625. doi: 10.1089/thy.2016.0409.
  36. The Prevalence, Incidence and Natural Course of Positive Antithyroperoxidase Antibodies in a Population-Based Study: Tehran Thyroid Study. Amouzegar A, Gharibzadeh S, Kazemian E, Mehran L, Tohidi M, Azizi F. PLoS One. 2017 Jan 4; 12 (1):e0169283. doi: 10.1371/journal.pone.0169283. eCollection 2017.
  37. Associations between anthropometric characteristics and insulin markers in mothers and their neonates and with neonate`s birth weight: An observational cohort study. Naseh A, Nourbakhsh S, Tohidi M, Sarkhail P, Najafian B, Azizi F. Turk J Pediatr. 2017; 59(6):625-635. doi: 10.24953/turkjped.2017.06.002.
  38.  Effects of levothyroxine treatment on pregnancy outcomes in pregnant women with autoimmune thyroid disease. Nazarpour S, Ramezani Tehrani F, Simbar M, Tohidi M, Alavi Majd H, Azizi F. Eur J Endocrinol. 2017 Feb; 176(2):253-265. doi: 10.1530/EJE-16-0548.
  39.  Inflammatory Properties of Diet and Glucose-Insulin Homeostasis in a Cohort of Iranian Adults. Moslehi N, Ehsani B, Mirmiran P, Shivappa N, Tohidi M, Hébert JR, Azizi F. Nutrients. 2016 Nov 18; 8 (11). pii: E735. doi: 10.3390/nu8110735.
  40.  The relation between changes in thyroid function and anthropometric indices during long-term follow-up of euthyroid subjects: the Tehran Thyroid Study (TTS). Motamed B, Eftekharzadeh A, Hosseinpanah F, Tohidi M, Hasheminia M, Azizi F. Eur J Endocrinol. 2016 Oct; 175(4):247-53. doi: 10.1530/EJE-16-0414.
  41.  Association between Dietary Acid Load and Insulin Resistance: Tehran Lipid and Glucose Study.  Moghadam SK, Bahadoran Z, Mirmiran P, Tohidi M, Azizi F. Prev Nutr Food Sci. 2016 Jun;21(2):104-9. doi: 10.3746/pnf.2016.21.2.104.
  42. Are serum nitric oxide metabolites associated with fasting insulin among Iranian adults? (Tehran Lipid and Glucose Study). Makhzani P, Afghan M, Tohidi M, Bagheripour F, Azizi F, Ghasemi A. Endocr Res. 2017 May; 42(2):96-101. doi: 10.1080/07435800.2016.1197933.
  43. Divergent pathway of lipid profile components for cardiovascular disease and mortality events: Results of over a decade follow-up among Iranian population.  Ghasemzadeh Z, Abdi H, Asgari S, Tohidi M, Khalili D, Valizadeh M, Moeini S, Eidkhani V, Azizi F, Hadaegh F. Nutr Metab (Lond). 2016 Jun 24; 13:43. doi: 10.1186/s12986-016-0102-1. eCollection 2016.
  44.  Hypothyroidism and Lipid Levels in a Community Based Study (TTS). Alamdari S, Amouzegar A, Tohidi M, Gharibzadeh S, Kheirkhah P, Kheirkhah P, Azizi F. Int J Endocrinol Metab. 2015 Nov 16; 14 (1):e22827. doi: 10.5812/ijem.22827. eCollection 2016 Jan.
  45.  . Thyroid and Pregnancy in Tehran, Iran: Objectives and Study Protocol. Nazarpour S, Ramezani Tehrani F, Simbar M, Tohidi M, Azizi F Int J Endocrinol Metab. 2016 Jan 30; 14 (1):e33477. doi: 10.5812/ijem.33477. eCollection 2016 Jan.
  46.  Change in fasting plasma glucose and incident type 2 diabetes mellitus: results from a prospective cohort study. Mozaffary A, Asgari S, Tohidi M, Kazempour-Ardebili S, Azizi F, Hadaegh F. BMJ Open. 2016 May 23; 6 (5):e010889. doi: 10.1136/bmjopen-2015-010889.
  47. Sex-specific incidence rates and risk factors of insulin resistance and β-cell dysfunction: a decade follow-up in a Middle Eastern population. Derakhshan A, Tohidi M, Hajebrahimi MA, Saadat N, Azizi F, Hadaegh F. Diabet Med. 2017 Feb;34(2):245-252. doi: 10.1111/dme.13117.
  48.  The effect of a single dose of vitamin D on glycemic status and C-reactive protein levels in type 2 diabetic patients with ischemic heart disease: a randomized clinical trial. Shaseb E, Tohidi M, Abbasinazari M, Khalili D, Talasaz AH, Omrani H, Hadaegh F. Acta Diabetol. 2016 Aug; 53(4):575-82. doi: 10.1007/s00592-016-0843-3.
  49.  Association between serum nitric oxide metabolites and thyroid hormones in a general population: Tehran Thyroid Study. Bagheripuor F, Gharibzadeh S, Ghanbari M, Amouzegar A, Tohidi M, Azizi F, Ghasemi A. Endocr Res. 2016 Aug;41(3):193-9. doi: 10.3109/07435800.2015.1126844.
  50. The Association between Blood Pressure and Normal Range Thyroid Function Tests in a Population Based Tehran Thyroid Study.  Amouzegar A, Heidari M, Gharibzadeh S, Mehran L, Tohidi M, Azizi F. Horm Metab Res. 2016 Mar;48(3):151-6. doi: 10.1055/s-0035-1564131.
  51.  Sex- and Age-Specific Reference Values and Cutoff Points for TPOAb: Tehran Thyroid Study. Thyroid. Amouzegar A, Bakhtiyari M, Mansournia MA, Etemadi A, Mehran L, Tohidi M, Azizi F. 2016 Mar;26(3):458-65. doi: 10.1089/thy.2015.0276.
  52. Which insulin resistance-based definition of metabolic syndrome has superior diagnostic value in detection of poor health-related quality of life? Cross-sectional findings from Tehran Lipid and Glucose Study. Deihim T, Amiri P, Taherian R, Tohidi M, Ghasemi A, Cheraghi L, Azizi F. Health Qual Life Outcomes. 2015 Dec 9; 13:194. doi: 10.1186/s12955-015-0391-5.
  53.  Dietary phytochemical index and the risk of insulin resistance and β-cell dysfunction: a prospective approach in Tehran lipid and glucose study. Bahadoran Z, Mirmiran P, Tohidi M, Azizi F. Int J Food Sci Nutr. 2015; 66(8):950-5. doi: 10.3109/09637486.2015.1111867.
  54.  Maternal Thyroid Function and Autoimmunity in 3 Trimesters of Pregnancy and their Offspring's Thyroid Function. Sarkhail P, Mehran L, Askari S, Tahmasebinejad Z, Tohidi M, Azizi F. Horm Metab Res. 2016 Jan;48(1):20-6. doi: 10.1055/s-0035-1555878.
  55. Is the association between insulin resistance and diabetogenic haematopoietically expressed homeobox (HHEX) polymorphism (rs1111875) affected by polycystic ovary syndrome status? Tehrani FR, Zarkesh M, Tohidi M, Azizi F, Zadeh-Vakili A. Reprod Fertil Dev. 2017 Apr;29(4):670-678. doi: 10.1071/RD15157.
  56.  Comparison of universal screening with targeted high-risk case finding for diagnosis of thyroid disorders. Nazarpour S, Tehrani FR, Simbar M, Tohidi M, AlaviMajd H, Azizi F. Eur J Endocrinol. 2016 Jan; 174(1):77-83. doi: 10.1530/EJE-15-0750.
  57. Different glucose tolerance status and incident cardiovascular disease and all-cause mortality among elderly Iranians. Mirbolouk M, Hajebrahimi MA, Akbarpour S, Tohidi M, Azizi F, Hadaegh F. Geriatr Gerontol Int. 2016 Dec;16(12):1263-1271. doi: 10.1111/ggi.12633.
  58. Trend of Cardio-Metabolic Risk Factors in Polycystic Ovary Syndrome: A Population-Based Prospective Cohort Study.  Ramezani Tehrani F, Montazeri SA, Hosseinpanah F, Cheraghi L, Erfani H, Tohidi M, Azizi F. PLoS One. 2015 Sep 11; 10(9):e0137609. doi: 10.1371/journal.pone.0137609. eCollection 2015.
  59.  Pomegranate (Punicagranatum) juice decreases lipid peroxidation, but has no effect on plasma advanced glycated end-products in adults with type 2 diabetes: a randomized double-blind clinical trial. Sohrab G, Angoorani P, Tohidi M, Tabibi H, Kimiagar M, Nasrollahzadeh J. Food Nutr Res. 2015 Sep 8;59:28551. doi: 10.3402/fnr.v59.28551. eCollection 2015.
  60. High-density lipoprotein cholesterol, a protective or a risk factor for developing coronary heart disease? Tehran Lipid and Glucose Study.  Hashemi Nazari SS, Shakiba M, Khalili D, Hadaegh F, Tohidi M, Azizi F. J Clin Lipidol. 2015 Jul-Aug; 9(4):553-8. doi: 10.1016/j.jacl.2015.04.001.
  61.  Does Twice-weekly Cabergoline Improve Anthropometrical and Biochemical Profiles in Prediabetes? A Randomized Double-blind Clinical Trial Pilot Study. Saadat N, Esmaily H, Abbasinazari M, Tohidi M, Salamzadeh J, Hadaegh F, Tolabi M, Kalantar-Hormozi M, Dibaj M. Iran J Pharm Res. 2015 Winter;14(Suppl):77-86.
  62.  Association between thyroid hormones, thyroid antibodies and insulin resistance in euthyroid individuals: A population-based cohort. Amouzegar A, Kazemian E, Gharibzadeh S, Mehran L, Tohidi M, Azizi F. Diabetes Metab. 2015 Dec; 41(6):480-8. doi: 10.1016/j.diabet.2015.04.004.
  63. Cut-off points of homeostasis model assessment of insulin resistance, beta-cell function, and fasting serum insulin to identify future type 2 diabetes: Tehran Lipid and Glucose Study.  Ghasemi A, Tohidi M, Derakhshan A, Hasheminia M, Azizi F, Hadaegh F. Acta Diabetol. 2015 Oct; 52(5):905-15. doi: 10.1007/s00592-015-0730-3.
  64.  Presence of hypertension modifies the impact of insulin resistance on incident cardiovascular disease in a Middle Eastern population: the Tehran Lipid and Glucose Study. Ghoreishian H, Tohidi M, Derakhshan A, Hajsheikholeslami F, Azizi F, Kazempour-Ardebili S, Hadaegh F. Diabet Med. 2015 Oct;32(10):1311-8. doi: 10.1111/dme.12733.
  65. Obesity Paradox and Risk of Mortality Events in Chronic Kidney Disease Patients: A Decade of Follow-up in Tehran Lipid and Glucose Study. Mohebi R, Simforoosh A, Tohidi M, Azizi F, Hadaegh F. J Ren Nutr. 2015 Jul; 25(4):345-50. doi: 10.1053/j.jrn.2014.12.006.
  66.  Dietary insulin load and insulin index are associated with the risk of insulin resistance: a prospective approach in tehran lipid and glucose study. Mirmiran P, Esfandiari S, Bahadoran Z, Tohidi M, Azizi FJ Diabetes Metab Disord. 2016 Jul 20; 15:23. doi: 10.1186/s40200-016-0247-5. eCollection 2015.
  67.  Trends in cardiovascular disease risk factors in people with and without diabetes mellitus: a Middle Eastern cohort study. Jahangiri-Noudeh Y, Akbarpour S, Lotfaliany M, Zafari N, Khalili D, Tohidi M, Mansournia MA, Azizi F, Hadaegh FPLoS One. 2014 Dec 2; 9 (12):e112639. doi: 10.1371/journal.pone.0112639. eCollection 2014.
  68.  Prevalence of hypothyroidism in patients with dyslipidemia: Tehran Thyroid Study (TTS).  Khazan M, Amouzegar A, Gharibzadeh S, Mehran L, Tohidi M, Azizi F. Horm Metab Res. 2014 Dec;46(13):980-4. doi: 10.1055/s-0034-1389997.
  69.  Sex-specific relations between fasting insulin, insulin resistance and incident hypertension: 8.9 years follow-up in a Middle-Eastern population. Arshi B, Tohidi M, Derakhshan A, Asgari S, Azizi F, Hadaegh F. J Hum Hypertens. 2015 Apr; 29(4):260-7. doi: 10.1038/jhh.2014.70.
  70. . Lipid profiles and ovarian reserve status: a longitudinal study. Tehrani FR, Erfani H, Cheraghi L, Tohidi M, Azizi FHum Reprod. 2014 Nov; 29(11):2522-9. doi: 10.1093/humrep/deu249.
  71. The prevalence of metabolic disorders in various phenotypes of polycystic ovary syndrome: a community based study in Southwest of Iran. Tehrani FR, Rashidi H, Khomami MB, Tohidi M, Azizi F. Reprod Biol Endocrinol. 2014 Sep 16; 12:89. doi: 10.1186/1477-7827-12-89.
  72.  Relationship of hyperinsulinaemia, insulin resistance and β-cell dysfunction with incident diabetes and pre-diabetes: the Tehran Lipid and Glucose Study. Derakhshan A, Tohidi M, Arshi B, Khalili D, Azizi F, Hadaegh F. Diabet Med. 2015 Jan;32(1):24-32. doi: 10.1111/dme.12560.
  73. Subclinical hypothyroidism and insulin resistance in polycystic ovary syndrome: is there a relationship?  Enzevaei A, Salehpour S, Tohidi M, Saharkhiz N. Iran J Reprod Med. 2014 Jul;12(7):481-6.
  74.  Serum free thyroxine concentration is associated with metabolic syndrome in euthyroid subjects.  Mehran L, Amouzegar A, Tohidi M, Moayedi M, Azizi F. Thyroid. 2014 Nov; 24(11):1566-74. doi: 10.1089/thy.2014.0103.
  75. Effects of pomegranate juice consumption on inflammatory markers in patients with type 2 diabetes: A randomized, placebo-controlled trial. Sohrab G, Nasrollahzadeh J, Zand H, Amiri Z, Tohidi M, Kimiagar M. J Res Med Sci. 2014 Mar;19(3):215-20.
  76. Changes in lipid measures and incident coronary heart disease: Tehran Lipid & Glucose Study. Nejat A, Mirbolouk M, Mohebi R, Hasheminia M, Tohidi M, Saadat N, Azizi F, Hadaegh F. Clin Biochem. 2014 Sep; 47(13-14):1239-44. doi: 10.1016/j.clinbiochem.2014.03.004.
  77.  Age- and sex-specific reference values for fasting serum insulin levels and insulin resistance/sensitivity indices in healthy Iranian adults: Tehran Lipid and Glucose Study. Tohidi M, Ghasemi A, Hadaegh F, Derakhshan A, Chary A, Azizi F. Clin Biochem. 2014 Apr; 47(6):432-8. doi: 10.1016/j.clinbiochem.2014.02.007.
  78. Secular trends in serum lipid levels of a Middle Eastern adult population; 10 years follow up in Tehran lipid and glucose study. Kheirandish M, Asgari S, Lotfaliany M, Bozorgmanesh M, Saadat N, Tohidi M, Azizi F, Hadaegh F. Lipids Health Dis. 2014 Jan 23;13:20. doi: 10.1186/1476-511X-13-20.
  79.  To what extent does the use of the Rotterdam criteria affect the prevalence of polycystic ovary syndrome? A community-based study from the Southwest of Iran. Rashidi H, Ramezani Tehrani F, Bahri Khomami M, Tohidi M, Azizi F. Eur J Obstet Gynecol Reprod Biol. 2014 Mar;174:100-5. doi: 10.1016/j.ejogrb.2013.12.018.
  80. Incidence of metabolic syndrome over 9 years follow-up; the importance of sex differences in the role of insulin resistance and other risk factors.  Hadaegh F, Hasheminia M, Lotfaliany M, Mohebi R, Azizi F, Tohidi M. PLoS One. 2013 Sep 27; 8(9):e76304. doi: 10.1371/journal.pone.0076304. eCollection 2013.
  81.  Predictors of the incident metabolic syndrome in healthy obese subjects: a decade of follow-up from the Tehran Lipid and Glucose Study. Hosseinpanah F, Nazeri P, Ghareh S, Tohidi M, Azizi F. Eur J Clin Nutr. 2014 Mar; 68(3):295-9. doi: 10.1038/ejcn.2013.142.
  82.  Reference limit of thyrotropin (TSH) and free thyroxine (FT4) in thyroperoxidase positive and negative subjects: a population based study. Amouzegar A, Delshad H, Mehran L, Tohidi M, Khafaji F, Azizi F. J Endocrinol Invest. 2013 Dec; 36(11):950-4. doi: 10.3275/9033.
  83.  Natural course of thyroid disease profile in a population in nutrition transition: Tehran Thyroid Study. Azizi F, Amouzegar A, Delshad H, Tohidi M, Mehran L, Mehrabi Y. Arch Iran Med. 2013 Jul;16(7):418-23. doi: 013167/AIM.0011.
  84.  Management of thyroid peroxidase antibody euthyroid women in pregnancy: comparison of the american thyroid association and the endocrine society guidelines. Mehran L, Tohidi M, Sarvghadi F, Delshad H, Amouzegar A, Soldin OP, Azizi F. J Thyroid Res. 2013;2013:542692. doi: 10.1155/2013/542692.
  85.  Non-linear association between 25-hydroxyvitamin D and the incidence of type 2 diabetes: a community-based nested case-control study. Tohidi M, Bozorgmanesh M, Mohebi R, Khalili D, Saadat N, Khorrami N, Azizi F, Hadaegh F. Diabet Med. 2013 Aug;30(8):934-8. doi: 10.1111/dme.12180.
  86. Lipid profile components and incident cerebrovascular events versus coronary heart disease; the result of 9 years follow-up in Tehran Lipid and Glucose Study. Tohidi M, Mohebi R, Cheraghi L, Hajsheikholeslami F, Aref S, Nouri S, Azizi F, Hadaegh F. Clin Biochem. 2013 Jun; 46(9):716-21. doi: 10.1016/j.clinbiochem.2013.03.012.
  87.  Absence of association between vitamin D deficiency and incident metabolic syndrome: Tehran Lipid and Glucose Study. Amirbaigloo A, Hosseinpanah F, Sarvghadi F, Tohidi M, Eskandary PS, Azizi F. Metab Syndr Relat Disord. 2013 Aug; 11(4):236-42. doi: 10.1089/met.2012.0121.
  88. Modeling age at menopause using serum concentration of anti-mullerian hormone.  Tehrani FR, Solaymani-Dodaran M, Tohidi M, Gohari MR, Azizi F. J Clin Endocrinol Metab. 2013 Feb; 98 (2):729-35. doi: 10.1210/jc.2012-3176. Erratum in: J Clin Endocrinol Metab. 2013 Apr; 98 (4):1766.
  89. Establishment of the trimester-specific reference range for free thyroxine index.  Azizi F, Mehran L, Amouzegar A, Delshad H, Tohidi M, Askari S, Hedayati M. Thyroid. 2013 Mar; 2 3(3):354-9. doi: 10.1089/thy.2012.0407. Erratum in: Thyroid. 2013 Jul; 23(7):915.
  90. Change in general and central adiposity measures in prediction of incident dysglycemia; Tehran Lipid and Glucose Study.  Hadaegh F, Jahangiri Noudeh Y, Tohidi M, Vatankhah N, Khalili D, Mohebi R, Azizi F. Prev Med. 2012 Dec;55(6):608-12. doi: 10.1016/j.ypmed.2012.09.025.
  91.  Incidence of chronic kidney disease and its risk factors, results of over 10 year follow up in an Iranian cohort. Tohidi M, Hasheminia M, Mohebi R, Khalili D, Hosseinpanah F, Yazdani B, Nasiri AA, Azizi F, Hadaegh F. PLoS One. 2012; 7 (9):e45304. doi: 10.1371/journal.pone.0045304.
  92. Adolescent lipoprotein classifications according to National Health and Nutrition Examination Survey (NHANES) vs. National Cholesterol Education Program (NCEP) for predicting abnormal lipid levels in adulthood in a Middle East population. Hatami M, Tohidi M, Mohebi R, Khalili D, Azizi F, Hadaegh F. Lipids Health Dis. 2012 Aug 31;11:107. doi: 10.1186/1476-511X-11-107.
  93.  Long-term continuous methimazole or radioiodine treatment for hyperthyroidism. Azizi F, Yousefi V, Bahrainian A, Sheikholeslami F, Tohidi M, Mehrabi Y. Arch Iran Med. 2012 Aug;15(8):477-84. doi: 012158/AIM.007.
  94. Effect of broccoli sprouts on insulin resistance in type 2 diabetic patients: a randomized double-blind clinical trial.  Bahadoran Z, Tohidi M, Nazeri P, Mehran M, Azizi F, Mirmiran P. Int J Food Sci Nutr. 2012 Nov; 63(7):767-71. doi: 10.3109/09637486.2012.665043.
  95.  Do different metabolic syndrome definitions predict cerebrovascular events and coronary heart disease independent of their components? : 9 years follow-up of the tehran lipid and glucose study. Hadaegh F, Mohebi R, Cheraghi L, Tohidi M, Moghaddam NB, Bozorogmanesh M, Sheikholeslami F, Azizi F. Stroke. 2012 Jun; 43(6):1669-71. doi: 10.1161/STROKEAHA.112.650812.
  96. The incidence of thyroid function abnormalities and natural course of subclinical thyroid disorders, Tehran, I.R. Iran.  Delshad H, Mehran L, Tohidi M, Assadi M, Azizi F. J Endocrinol Invest. 2012 May; 35(5):516-21. doi: 10.3275/7968.
  97. Subclinical hypothyroidism in pregnancy: intellectual development of offspring. Behrooz HG, Tohidi M, Mehrabi Y, Behrooz EG, Tehranidoost M, Azizi F. Thyroid. 2011 Oct; 21(10):1143-7. doi: 10.1089/thy.2011.0053
  98. Triglycerides and triglycerides to high-density lipoprotein cholesterol ratio are strong predictors of incident hypertension in Middle Eastern women.  Tohidi M, Hatami M, Hadaegh F, Azizi F. J Hum Hypertens. 2012 Sep; 26(9):525-32. doi: 10.1038/jhh.2011.70.
  99.  The prevalence of polycystic ovary syndrome in a community sample of Iranian population: Iranian PCOS prevalence study. Tehrani FR, Simbar M, Tohidi M, Hosseinpanah F, Azizi F. Reprod Biol Endocrinol. 2011 Mar 25; 9:39. doi: 10.1186/1477-7827-9-39.
  100.  Intra-erythrocyte magnesium is associated with gamma-glutamyl transferase in obese children and adolescents. Tohidi M, Ghasemi A, Hadaegh F, Arbabi S, Hosseini Isfahani F. Biol Trace Elem Res. 2011 Nov;143(2):835-43. doi: 10.1007/s12011-010-8949-x.
  101.  Neonatal thyroid status in an area of iodine sufficiency. Azizi F, Hosseini MS, Amouzegar A, Tohidi M, Ainy E. J Endocrinol Invest. 2011 Mar; 34(3):197-200. doi: 10.3275/7295.
  102. Lipid ratios and appropriate cut off values for prediction of diabetes: a cohort of Iranian men and women. Hadaegh F, Hatami M, Tohidi M, Sarbakhsh P, Saadat N, Azizi F. Lipids Health Dis. 2010 Aug 17;9:85. doi: 10.1186/1476-511X-9-85.
  103.  Lipid measures for prediction of incident cardiovascular disease in diabetic and non-diabetic adults: results of the 8.6 years follow-up of a population based cohort study. Tohidi M, Hatami M, Hadaegh F, Safarkhani M, Harati H, Azizi F. Lipids Health Dis. 2010 Jan 23;9:6. doi: 10.1186/1476-511X-9-6.
  104. Glucose intolerance and risk of cardiovascular disease in Iranian men and women: results of the 7.6-year follow-up of the Tehran Lipid and Glucose Study (TLGS). Hadaegh F, Khalili D, Fahimfar N, Tohidi M, Eskandari F, Azizi F. J Endocrinol Invest. 2009 Oct; 32(9):724-30. doi: 10.3275/6399.
  105.  Impaired fasting glucose cutoff value of 5.6 mmol/l combined with other cardiovascular risk markers is a better predictor for incident Type 2 diabetes than the 6.1 mmol/l value: Tehran lipid and glucose study. Harati H, Hadaegh F, Tohidi M, Azizi F. Diabetes Res Clin Pract. 2009 Jul; 85(1):90-5. doi: 10.1016/j.diabres.2009.04.006.
  106. Prevalence of metabolic syndrome by the Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions and their association with coronary heart disease in an elderly Iranian population.  Hadaegh F, Zabetian A, Tohidi M, Ghasemi A, Sheikholeslami F, Azizi F. Ann Acad Med Singapore. 2009 Feb; 38(2):142-9.
  107. Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II. Azizi F, Ghanbarian A, Momenan AA, Hadaegh F, Mirmiran P, Hedayati M, Mehrabi Y, Zahedi-Asl S; Tehran Lipid and Glucose Study Group.. Trials. 2009 Jan 25; 10:5. doi: 10.1186/1745-6215-10-5.
  108.  Triglyceride/HDL-cholesterol ratio is an independent predictor for coronary heart disease in a population of Iranian men. Hadaegh F, Khalili D, Ghasemi A, Tohidi M, Sheikholeslami F, Azizi F. Nutr Metab Cardiovasc Dis. 2009 Jul;19(6):401-8. doi: 10.1016/j.numecd.2008.09.003.
  109. Association of liver enzymes with incident type 2 diabetes: A nested case control study in an Iranian population. Tohidi M, Harati H, Hadaegh F, Mehrabi Y, Azizi F. BMC Endocr Disord. 2008 Jun 5; 8:5. doi: 10.1186/1472-6823-8-5.
  110. The metabolic syndrome and incident diabetes: Assessment of alternative definitions of the metabolic syndrome in an Iranian urban population.  Hadaegh F, Ghasemi A, Padyab M, Tohidi M, Azizi F. Diabetes Res Clin Pract. 2008 May; 80(2):328-34. doi: 10.1016/j.diabres.2008.01.003.
  111. C-reactive protein in risk prediction of cardiovascular outcomes: Tehran Lipid and Glucose Study. Tohidi M, Hadaegh F, Harati H, Azizi F. Int J Cardiol. 2009 Mar 6; 132(3):369-74. doi: 10.1016/j.ijcard.2007.11.085.
  112.  Using common clinical data improves the prediction of abnormal glucose tolerance by the new criteria of impaired fasting glucose: Tehran lipid and glucose study. Hadaegh F, Harati H, Ghasemi A, Tohidi M, Zabetian A, Mehrabi Y, Azizi F. Diabetes Res Clin Pract. 2007 Sep; 77(3):459-64. Prevalence of gestational diabetes mellitus in southern Iran (Bandar Abbas City). Hadaegh F, Tohidi M, Harati H, Kheirandish M, Rahimi S.          Endocr Pract. 2005 Sep-Oct; 11 (5):313-8.

 

Farsi

  1. اصلاح فرمول فریدوالد برای محاسبه غلظت لیپوپروتیین کم چگال (LDL) در جمعیت ایرانی. اصغر قاسمی، سمانه عسگری، پروفسور فرزاد حدائق، فریدون عزیزی، مریم توحیدی.1397، . دوره ۲۰، شماره 3، صفحات 108-107.
  2.  اختلالات تحت بالینی عملکرد تیروئید و بروز بیماری‌ های قلبی و عروقی: مطالعه‌ی تیروئید تهران. آیدین باغبانی اسکوئی، سمانه اکبرپور، مریم توحیدی، عطیه آموزگار، لادن مهران، فرزاد حدائق، فریدون عزیزی. 1397،  دوره۲۰، شماره 1، صفحات 9-1.
  3. اثر تجویز خوراکی نیترات سدیم بر شمارش سلول‌های خونی در موش‌های صحرایی نر چاق و مبتلا به دیابت نوع 2 . وجیهه خراسانی، پریچهر یغمایی، مریم توحیدی، سودا غیبی، طرلان ورزندی، اصغر قاسمی. 1396، دوره ۱۹، شماره ۵ ، صفحات 348-340.
  4. شیوع و بروز اختلالات عملکرد تیروئید در بیماران با سن بالاتر از ۵۵ سال (مطالعه تیروئید تهران). محبوبه سادات حسینی، عطیه آموزگار، مریم توحیدی، ژاله طهماسبی نژاد، فریدون عزیزی. 1395، دوره ۱۸، شماره ۳، صفحات 172-165.
  5. غربالگری عمومی با بیماریابی افراد پرخطر اختلالات تیروئیدی زنان باردار. سیما نظرپور، فهیمه رمضانی تهرانی، معصومه سیمبر، مریم توحیدی، حمید علوی مجد، فریدون عزیزی. پژوهش در پزشکي، 1394،  دوره  ۳۹ , شماره  ۳، 151-145.
  6. بررسی همبستگی آندروژن‌های سرم با عملکرد جنسی زنان یائسه. سهیلا نظرپور، معصومه سیمبر، فهیمه رمضانی تهرانی، مریم توحیدی، حمید علوی مجد. 1394،  دوره ۱۷، شماره ۱ ، صفحات 22-13.
  7.  بروز اختلالات عملکردی تیروئید در بیماران دیابتی نوع 2: دوازده سال پیگیری در مطالعه قند و لیپید تهران. میرصابر سادات امینی، حسین دلشاد، عطیه آموزگار، مریم توحیدی، فریدون عزیزی. مجله غدد درون ریز و متابولیسم ایران، 1394، دوره 17، شماره 1، صفخات 12-4.
  8.  تقلید علائم و نشانه های اختلالات تیروئیدی در زنان حامله سالم، مطالعه مبتنی بر جمعیت. سیما نظرپور، فهيمه رمضاني تهراني ، معصومه سیمبر، مریم توحیدی، حمید علوی مجد، فریدون عزیزی. 1394، دوره 17، شماره 3 صفخات189-181.
  9.  رابطه ي كم كاري تيروئيد تحت باليني با سندرم متابوليک، مطالعه اي مبتني برجمعيت در زنان سنين باروري چهار استان کشور. فهيمه رمضاني تهراني، مریم توحیدی ،مرضيه رستمي، سحر عسگري، فريدون عزیزی.  مجله غدد درون ریز و متابولیسم ایران، 1390 دوره 13، شماره 1، صفحات 105-98.
  10. بررسی تاثیر دو میزان پودر جوانه بروکلی بر پراکسیداسیون لیپیدی و تعادل اکسیدانی آنتی اکسیدانی در مبتلایان به دیابت نوع 2.  زهرا بهادران، پروین میرمیران، مریم توحیدی، مهیا مهران، فریدون عزیزی. پژوهش در پزشکي، 1390، دوره  ۳۵ , شماره  ۴، صفحات 220-215.
  11.  میزان بروز اختلال عملکرد و سیر طبیعی اختلال های زیر بالینی تیروئید در بزرگسالان تهرانی. مژگان اسدی،  حسین دلشاد،  مریم توحیدی،  فریدون عزیزی. مجله غدد درون ریز و متابولیسم ، 1388،  دوره 11 شماره 6، صفحات 679-673.
  12.  ارتباط سندرم متابوليك واجزاي آن با بيماريهاي كرونري قلبي در زنان و مردان ايراني: مطالعه قند و ليپيد تهران. فرزاد حدائق،  آزاده ضابطیان،  مریم توحیدی، فریدون عزیزی. مجله دانشکده پزشکی دانشگاه علوم پزشکی تهران، 1387، دوره 66 شماره 8 صفحات 598-590 .
  13.  عملکرد تیروئید، عملکرد شناختی و بهره ی هوشی در کودکان مادران مبتلا به تیروئیدیت پس از زایمان. مهتاب نیرومند،  مهدی تهرانی دوست،  مریم توحیدی ، غزاله زرگری نژاد،  فریدون عزیزی.  مجله غدد درون ریز و متابولیسم ایران، 1387،  دوره 10، شماره 5، صفحات 482-473.
  14. نقش پروتئین واکنشگرC (CRP) در پیش‌بینی بروز دیابت نوع ۲ در مطالعه‌ی قند و لیپید تهران. محمد ابراهیمی، مریم توحیدی، فرزاد حدائق، فریدون عزیزی. 1387، دوره ۱۰، شماره ۱ ، صفحات 16-11.
  15.  نقش پروتئین واکنش‌گر C در پیش‌بینی رخدادهای قلبی ـ عروقی: مطالعه‌ی قند و لیپید تهران. مریم توحیدی، فرزاد حدائق، هادی هراتی، فریدون عزیزی. 1386، دوره ۹، شماره ۲، صفحات 169-161.
  16. بررسی پلی‌مورفیسم آپولیپوپروتئین E در ارتباط با میزان چاقی در مطالعه‌ی قند و لیپید تهران. مهدی هدایتی، فرهاد حسین پناه، فرزانه سروقدی، مریم توحیدی، مریم السادات دانشپور، پریسا اشراقی، فریدون عزیزی. 1386، دوره 9، شماره ۱، صفحات 90-85.
  17. خطر منتسب جمعیت در مورد ارتباط دیابت با چاقی در بزرگسالان ایرانی. فرهاد حسین پناه، مهدی رامبد، فرزانه سروقدی، مریم توحیدی، مهدی هدایتی، فریدون عزیزی. 1386، دوره ۹، شماره 1، صفحات 97-91.
  18. شیوع چاقی در افراد بالای ۵۰ سال شهر تهران. فرزانه سروقدی، مهدی رامبد، فرهاد حسین پناه، مهدی هدایتی، مریم توحیدی، فریدون عزیزی. 1386، دوره ۹، شماره 1، صفحات 104-99.
  19.  پادتن ضد کاردیولیپین در بیماران مبتلا به دیابت نوع 1. مریم توحیدی، فرزاد حدائق، هادی هراتی، سید علیرضا سبحانی، مرجان فرشادی، پریسا استعانه.  مجله غدد درون ریز و متابولیسم ایران، 1384،  دوره 7 ، شماره 4، صفحات 254-347.
  20.  ارزش تشخیصی سیتولوژی آسپیراسیون سوزنی ظریف در ارزیابی گره های تیروئید: یک بررسی هشت ساله در استان هرمزگان. مریم توحیدی، سید عبداله موسوی ، فرزاد حدائق ، سید علیرضا سبحانی. مجله غدد درون¬ریز و متابولیسم ایران، 1384،  سال هفتم شماره یک، صفحات 30-21.
  21.  معرفی یک مورد متاستاز منفرد جمجمه از کارسینوم فولیکولار تیروئید. مریم توحیدی،  سید عبداله موسوی،  فرزاد حدائق.  مجله پزشکی هرمزگان، 1383، سال هشتم شماره چهارم صفحات 244-239.
  22.  اختلالات خودايمني تيروئيد در بيماران مبتلا به ديابت نوع 1 در جنوب ايران(شهر بندرعباس). فرزاد حدائق، مریم توحیدی، هادی هراتی، مرجان فرشادی، پریسا استعانه. : مجله ديابت و ليپيد ايران. 1383،  دوره 4 شماره 1 صفحات 72-65.
  23.  بررسی لیپیدهای سرم و آزمونهای تیروئیدی در افراد مسن ساکن خانه سالمندان استان هرمزگان. مریم توحیدی،  فرزاد حدائق، الهام بوشهری.  مجله پزشکی هرمزگان، 1383،  سال هشتم ، شماره اول صفحات 19-26.
  24.  رشد و بلوغ در مبتلایان به تالاسمی ماژور استان هرمزگان. فرزاد حدائق،  شهرام زارع،  مریم توحیدی.  مجله غدد درون ریز و متابولیسم، 1382،  سال پنجم،شمارة۳،صفحه هاي ۱۹۳-۱۸۷.
  25.   بررسی عملکرد محور هیپوفیز- تیروئید و متابولیسم کلسیم و فسفر در مبتلایان به تالاسمی ماژور استان هرمزگان. فرزاد حدائق،  شهرام زارع،  مریم توحیدی،  امید صفا،  خاطره ماهوری. مجله پزشکی هرمزگان، 1381،  سال ششم ، دوره 2، صفخات 1-6.
  26.   ارزیابی نتایج آسپیراسیون سوزنی تیروئید در استان هرمزگان یک بررسی سه ساله.  مریم توحیدی،  سید علیرضا سبحانی . مجله طب جنوب، 1378، سال دوم شماره دوم.